Literature DB >> 24140635

Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells.

Can-Jie Guo1, Qin Pan, Hua Xiong, Yu-Qi Qiao, Zhao-Lian Bian, Wei Zhong, Li Sheng, Hai Li, Lei Shen, Jing Hua, Xiong Ma, Jing-Yuan Fang.   

Abstract

In our previous study, miR-126 was identified as one of the leading miRNAs that is downregulated during activation of hepatic stellate cells (HSCs). However, the roles and related mechanisms of miR-126 in HSCs are not understood. In this study, we compared expression of miR-126 during HSC activation both in vitro and in vivo. We also applied RNA interference to analyze the role and mechanism of miR-126(*) in the activation of HSCs. Restoring HSCs with Lv-miR-126(*) resulted in decreased proliferation, accumulation of extracellular matrix components, and cell contraction, while also negatively regulating the vascular endothelial growth factor (VEGF) signal transduction pathways by partially targeted VEGF-A. Thus, we postulate that miR-126 may be a biological marker for the activation of HSCs, and useful for reducing intrahepatic vascular resistance and improving the sinusoidal microcirculation in chronic liver diseases.
Copyright © 2013 Federation of European Biochemical Societies. All rights reserved.

Entities:  

Keywords:  3′UTR; 3′untranslated region; Akt; COL IV; Chronic liver disease; ECM; EGFL7; GO; HA; HE; HSC; Hepatic stellate cell; KEGG; LN; PCIII; PI3K; Portal hypertension; VEGF; VEGFA; VG; Van Gieson; epidermal growth factor-1ike domain 7; extracellular matrix; gene ontology; hematoxylin/eosin; hepatic stellate cell; hyalaronic acid; kyoto encyclopedia of genes and genomes; laminin; miR-126(∗); miRNA; microRNA; phosphatidylinositol-3-kinase; procollagen typeIII; protein kinase B; type IV collagen; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 24140635     DOI: 10.1016/j.febslet.2013.09.047

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

2.  Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.

Authors:  Hongxia Chen; Lingmin Li; Shaojun Wang; Yupeng Lei; Qi Ge; Nonghua Lv; Xiaodong Zhou; Changyan Chen
Journal:  Oncotarget       Date:  2014-12-15

3.  Epigenetic Changes during Hepatic Stellate Cell Activation.

Authors:  Silke Götze; Eva C Schumacher; Claus Kordes; Dieter Häussinger
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

4.  Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells.

Authors:  Mar Coll; Adil El Taghdouini; Luis Perea; Inge Mannaerts; Maria Vila-Casadesús; Delia Blaya; Daniel Rodrigo-Torres; Silvia Affò; Oriol Morales-Ibanez; Isabel Graupera; Juan José Lozano; Mustapha Najimi; Etienne Sokal; Joeri Lambrecht; Pere Ginès; Leo A van Grunsven; Pau Sancho-Bru
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

5.  MicroRNAs shape circadian hepatic gene expression on a transcriptome-wide scale.

Authors:  Ngoc-Hien Du; Alaaddin Bulak Arpat; Mara De Matos; David Gatfield
Journal:  Elife       Date:  2014-05-27       Impact factor: 8.140

6.  Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ.

Authors:  Davide Povero; Nadia Panera; Akiko Eguchi; Casey D Johnson; Bettina G Papouchado; Lucas de Araujo Horcel; Eva M Pinatel; Anna Alisi; Valerio Nobili; Ariel E Feldstein
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-11-01

Review 7.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.

Authors:  Szu-Yi Liu; I-Ting Tsai; Yin-Chou Hsu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

8.  RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.

Authors:  Scott M Riester; Diren Arsoy; Emily T Camilleri; Amel Dudakovic; Christopher R Paradise; Jared M Evans; Jorge Torres-Mora; Marco Rizzo; Peter Kloen; Marianna Kruithof-de Julio; Andre J van Wijnen; Sanjeev Kakar
Journal:  BMC Med Genomics       Date:  2015-10-07       Impact factor: 3.063

Review 9.  Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?

Authors:  Can-Jie Guo; Qin Pan; Hua Xiong; Yu-Qi Qiao; Zhao-Lian Bian; Wei Zhong; Li Sheng; Hai Li; Lei Shen; Jing Hua; Xiong Ma
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

Review 10.  Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis.

Authors:  Mio Kitano; P Mark Bloomston
Journal:  J Clin Med       Date:  2016-03-16       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.